{"name":"Tubulis GmbH","slug":"tubulis-gmbh","ticker":"","exchange":"","domain":"tubulisgmbh.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TUB-040","genericName":"TUB-040","slug":"tub-040","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TUB-040","genericName":"TUB-040","slug":"tub-040","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOUGNSRm5Yc0IxZ0lvMDRibFcwdkh6U0pwbUZCWGpDSk0zcXljUUFjdXFkMVV0eXdaVTVxd1NPRFEwRl9JdlpEMFNzR29zREdSX0Q0Nm1PTGdfUnpKSmhGaS1GMlN2QUlIYkh3SXNOMHV6MldwdGlFUTdrdVJscDlDMW1FSGY1OVF2bk11LWlrR3VVLUZQVlc1dEFXUm0?oc=5","date":"2026-04-07","type":"deal","source":"Reuters","summary":"Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline - Reuters","headline":"Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNQkNGVzd2UmxqMXhLS1NERHdUUDBOdzFXaDFZMmNZZTZ0ZTFvVlFrY0twUTNkZXRKa3JNc1k4RnhlQVM4Y3FkN1JlOFhGZ2VtMUs5aVYxYXp5cjU2ckxRRjdqTzF6c1N6aWgtV2dlV25tempJLV9xT09uSGUwX0txWDVaTFVZWXFHUy05U0oxVFFsTDRoelhrVUNPUFBWeWhxT3FmM2F3Ylo0R21iTWZTdGFSeURxS1h3UXF4cWhjbW1rTERfUEpBbUJfMFd0Z0VGMWhrVnhxRHNWZVNCbTc3Uk91TlhDQ3plS0NpNmk4Qk9YaUozVXhkU1pMSjJyUWtwYzQ1ZlRsN0U0TjVkSGNwNWJUQ28xbTdfMXYtUmVyTnY2MENsRlJPcFFuSEZTWWRJWWc?oc=5","date":"2026-04-07","type":"deal","source":"Business Wire","summary":"Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline - Business Wire","headline":"Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Furth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNNExIdWhWVGpZdWxNQWxYTjRBR1M4ck1FcG1neFR5dzUwVG5maG5xOFZWbVpMU1ctOHRlaG84TzhsV1ppdzR6ZFJFQ1pUOTQwUnJpaVBDWnFnWmRsb1h3R2lsamdHa1pMZ01zUmNHdzBRSWRQZWJPTC1wejhVbjJ2NzNLZkt5VnJUdWNpTURHbno?oc=5","date":"2026-04-07","type":"deal","source":"Contract Pharma","summary":"Gilead Sciences Agrees to Acquire Tubulis - Contract Pharma","headline":"Gilead Sciences Agrees to Acquire Tubulis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNM0JPRHZBbXFjOG1iN3NjYjg1LWVDa2VTeTc1Ym9kdjBUdFpUZ1NQVFJBb3ZTMlBzd2hqVjJ3b3M1Uy1rSEpobThxT01ueTFyUHZRYWdUU1N5c3BSZVpNMzN3YjlhVTR6U3hpS0RNQU54NkJHYTRxdnJZZWppS0wwNFBfTGNiR0k?oc=5","date":"2026-04-07","type":"deal","source":"Pharmaceutical Executive","summary":"Gilead Enters $5 Billion Agreement to Acquire Tubulis - Pharmaceutical Executive","headline":"Gilead Enters $5 Billion Agreement to Acquire Tubulis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPYjktVGhCdi1PcmttSzRTa0RLNHgxZ2pSS0FFbGNISmFRd0xpZDJWS0hNLWNKaHoyb2FWaExzRHZRQUw4Vlc0UnB1Tm56aUFVYlZ1bS0zdnVZcUpUNGFBRHhUTHVrSmFzbmx6cllCNVlULWN5bTBleVJnemxHMmlZMXVGLVc1b0JOZE5uS0NPU1c?oc=5","date":"2026-04-07","type":"deal","source":"The Pharma Letter","summary":"Gilead goes big with $5 billion Tubulis buy - The Pharma Letter","headline":"Gilead goes big with $5 billion Tubulis buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQUnF0d3R3RjZlUVBJOWRlRkwtdVJXX1R3bWFNR1lrWS1jSXY0dzMtWEI2bUJXQVV5c3JqQUNmSE52U1BuQndUaEpzTkFVRGlERjhTcjc3WEl5V2pvTHlZRVkyXzdhUUdDV1R0WFJOTDhkdVhmdy1zOXBzZklGZjAzYm1sdW91X1dXNTRHWXpxUWxrUGVleDJBUEVOU3FQNlhZQS1kSTcxZGpiQzg?oc=5","date":"2026-04-07","type":"deal","source":"European Biotechnology Magazine","summary":"Gilead acquires German ADC specialist Tubulis in US$5bn deal - European Biotechnology Magazine","headline":"Gilead acquires German ADC specialist Tubulis in US$5bn deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQN3dVTkg5OHY5eFdET1NDLVBRVDhPSkFLdW5tS2xfTlFMZWVMWV9BRTM2M1dpWThBVENDczJMbldHYnJMMkdZTUJUQW11VU9mSFRlSENCUUtpQkFLcFR3eldFVVVCclVpT2s4U2tPczJNU3paU1NYc2t5N0dzZmE0RGJRc3BoeVpGWjk1cnR0YWJUVzJsU3RVd0xHc3RGUkVYTmdoMUVn?oc=5","date":"2026-04-07","type":"deal","source":"PharmaLive","summary":"Gilead to buy Germany’s Tubulis for up to $5 billion to boost cancer pipeline - PharmaLive","headline":"Gilead to buy Germany’s Tubulis for up to $5 billion to boost cancer pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxObXJzY3FnOHFDS3MyNER1QVM2SGVWNjZTaW5OYm5ZUFd1aG9fSW1NNEUwSWxIbk82MGJBQ1RNMnVZOU1CWGtGXzVqOFk5VzU0M3ZPUkFKMm5VZ3lKZG40ZDR5U3VDVERRYS1NYjRYX21OYTM4UXEydGNPUG5ZYTM4WnZhWDVzYlhRYzNmUW9pdVp4R0hGY01heEQ0OFZJazZXQXdYSjkwbVF4TzFQZk1FT0lDVjFLemdu?oc=5","date":"2026-01-31","type":"pipeline","source":"finviz.com","summary":"UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook - finviz.com","headline":"UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNdV9QM0tqbmlUQU5CWlk3ZkpTaDdRaVMyNGFBa0NUUFZJOTdvNDVGaUJxUzVtZTloMnN1Vnd0bDJVUFNGLW9mZ3ZWMzdWNkhZdzZFUTRnUFh5V0U3Z05rcUZMTWNkTG4zdm9nLWhyWVZZNHduakRuOENhbjRvV2piNW1md3haeFItQ09qTHJPa2tUZDZCdS1veA?oc=5","date":"2026-01-09","type":"pipeline","source":"Fierce Biotech","summary":"Former Roche oncology head turns to Tubulis—Chutes & Ladders - Fierce Biotech","headline":"Former Roche oncology head turns to Tubulis—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQU3k0UTQ4U2hwZk1sZkFHMW9XajdqSFktTC1nVkZVWnZtQXlUVE15SDNFTEM5N3hWb2sxeXVpZmYtX3Jqa280aGtnT1BkSVVrRjJsaXhpZGtZZHFrdkFPakI2bEtESE8tZGFybFhaRVljOGptUFBqdnlLQVBVZVI3N0J2cFB4bk9HYXdfYjJZQXprLVNoOEJPekZJVFNNNk56TVZMUDhibjd6M1FoUVZXWHFhcFI4QQ?oc=5","date":"2025-10-19","type":"pipeline","source":"Fierce Biotech","summary":"ESMO: Tubulis’ next-gen ADC posts 59% response rate, justifying investor interest - Fierce Biotech","headline":"ESMO: Tubulis’ next-gen ADC posts 59% response rate, justifying investor interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNc0NvQ1NudDZYa0VMMldXVTJJQXdHdkFvTXJwc3hOaDctTEl3UTQwUm4tVkI5NU9NUnRRMk9ZYlFWNEZjQ2p1dnRZSnNUSDlvb2F0NkJ2RTlSNDI4VnJkaGduRUhaYVAxTFJNeTNSeHhTZU8xSy14T09hY3VLWlZzN2ItbU40NHpRTnA4M1JobUpQOXYxRnNpcE9UOU9ENVE?oc=5","date":"2025-10-15","type":"pipeline","source":"BioPharma Dive","summary":"Cancer drug startup Tubulis raises $361 million for ADCs - BioPharma Dive","headline":"Cancer drug startup Tubulis raises $361 million for ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOZElYcFJFWUdTZEZNTnpza3hsZUw3WXVfMUZUdlZoTTZDV1RXOHY4UXF2M1lkUHVKaFR6MUduWm1PQ244cWhTSEZHSEUwR040c0JCc1laS2V5R1VPbWFnOC1rZ2lNd0JnZ3MwTGJUeTlKME1zTldlQ0YxdlJtUjVjVHBseVdtV0NKWFUzSFdFN2FjTWZibFdSck5RY2J3MkRfRGY0eXMwVThzbGlBRmZpVkd4aF94OUw2WDI5TWtLZHhLQ2o0YWlsMndMWUpzX3RiYWJrLVpDY1RxUQ?oc=5","date":"2025-10-15","type":"pipeline","source":"Reuters","summary":"German biotech firm Tubulis raises $358 million to develop targeted cancer treatments - Reuters","headline":"German biotech firm Tubulis raises $358 million to develop targeted cancer treatments","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}